Stocks / Biotech

KODBiotech

Kodiak Sciences Inc
$32.851d -0.5%5d -0.1%settled close · 2026-09-17
Mkt cap $1.3B (3/25)β 1.1752w $30–48Shares 53.0MInd. Biological Products, (No Diagnostic Substances)Nasdaq since 2018Emp. 121HQ Palo Alto, CAkodiak.com
Who’s talkingIdea Scout · free

Who’s talking about KOD

No tracked investor commentary on KOD yet — the corpus grows weekly.
Idea Scout tracks who’s talking across television, podcasts, and interviews — every stance dated to the appearance it came from. Sign up free →
Earnings

Next report: 11 Nov 2026

Confirmed date · consensus EPS -1.02. Reactions below are the next settled session over the prior close.
ReportWhenEPS actual vs est.Reaction
13 Aug 2026after the close-1.05 vs -0.97+2.0%
The options tape

Notable options days

Sessions in the last 120 where KOD’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 8 of 120 sessions qualified.

The qualifying dates are the free record. Close, flow, call/LEAPS mix and the 20-session outcome — for every session below — are Brief subscriber content.
DateCloseRVOL Δ$ flow ($M)Call % LEAPS %+20 sess.
2026-09-16
2026-09-09
2026-08-26
2026-08-13
2026-07-10
2026-07-08
2026-07-07
2026-06-25
+20 sess. = raw price change over the following 20 sessions — not market-adjusted; the tape tells you where to look, not what happens next.
Today’s tape on KOD is in this morning’s Brief. Get The Brief — $20/mo →